중앙백신
072020KOSDAQ기초 의약물질 제조업56.0 / 100
Reference Date: 2026-06-10
Company InformationBased on 2025 Annual Report
Business Overview
Central Vaccine is a company specializing in the development and production of animal vaccines and biological products, focusing on disease prevention and control in the livestock industry. Recent outbreaks of African Swine Fever and Highly Pathogenic Avian Influenza have increased demand for vaccines, necessitating the development of new products to counteract the diminishing efficacy of existing ones. The company is expanding into new markets, including China and Brazil, to broaden its global presence.
Number of Employees
194people
Average Salary
57.1M KRW
Score Calculation Basis
Detailed Financial Score
Lower than industry avg (good)
Half of industry avg (excellent)
Well below industry avg
In line with industry avg
Avg ▲8.3% (2-year basis)
Avg ▼2.6% (2-year basis)
Avg ROE 6.3% (declining, 3yr)
Detailed News Sentiment
Detailed Momentum
52w mid range (44%)
1m -5.06% (slight drop)
Volume decreasing
Detailed Disclosure
- Neutral분기보고서 (2026.03)2026-05-15
